CLINICAL TRIALS PROFILE FOR ULIMORELIN
✉ Email this page to a colleague
Clinical Trials for Ulimorelin
| Trial ID | Title | Status | Sponsor | Phase | Summary |
|---|---|---|---|---|---|
| NCT01285570 ↗ | Ulimorelin Study of Efficacy and Safety (ULISES 007) | Completed | Norgine | Phase 3 | Post-operative administration of ulimorelin is expected to reduce time to recovery of Gastrointestinal (GI) function in patients who have undergone partial large bowel resection. |
| NCT01285570 ↗ | Ulimorelin Study of Efficacy and Safety (ULISES 007) | Completed | Tranzyme, Inc. | Phase 3 | Post-operative administration of ulimorelin is expected to reduce time to recovery of Gastrointestinal (GI) function in patients who have undergone partial large bowel resection. |
| NCT01296620 ↗ | Ulimorelin Study of Efficacy and Safety (ULISES 008) | Completed | Norgine | Phase 3 | Post-operative administration of ulimorelin is expected to reduce time to recovery of Gastrointestinal (GI) function in patients who have undergone partial large bowel resection |
| NCT01296620 ↗ | Ulimorelin Study of Efficacy and Safety (ULISES 008) | Completed | Tranzyme, Inc. | Phase 3 | Post-operative administration of ulimorelin is expected to reduce time to recovery of Gastrointestinal (GI) function in patients who have undergone partial large bowel resection |
| NCT01405599 ↗ | Evaluation of the Pharmacokinetics of Ulimorelin in Subjects With Hepatic Impairment and Healthy Subjects | Completed | Norgine | Phase 1 | Evaluation of the effect of hepatic impairment on the pharmacokinetics of ulimorelin after a single intravenous (IV) dose in order to identify potential patients at risks in terms of severity of hepatic dysfunction and to determine whether their dosage should be adjusted. |
| NCT01405612 ↗ | Study to Examine the Effect of Ulimorelin on the Pharmacokinetics of Midazolam in Healthy Volunteers | Completed | Norgine | Phase 1 | An open-label, single centre, randomised, cross-over study to examine the effect of ulimorelin on the pharmacokinetics of midazolam after repeat dose administration of ulimorelin in healthy volunteers. |
| NCT01710982 ↗ | A Study to Evaluate the Safety of TZP-101 (IV Ulimorelin) Administered Post-Operatively in Patients Who Have Undergone Partial Bowel Resection | Completed | Norgine | Phase 3 | A study to evaluate the safety of TZP-101 in comparison with placebo when administered post-operatively in patients who have undergone partial bowel resection. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Summary |
Clinical Trial Conditions for Ulimorelin
Condition Name
Clinical Trial Locations for Ulimorelin
Trials by Country
Clinical Trial Progress for Ulimorelin
Clinical Trial Phase
Clinical Trial Sponsors for Ulimorelin
Sponsor Name
